HSV Treatment Readies for Approval — Precision Vaccinations News
Mar 29, 2023 · Pritelivir is a nonnucleoside helicase primase inhibitor against HSV. Germany (Precision Vaccinations News). A recently published Original Article reported positive news regarding the First-in-Human clinical trials assessing Pritelivir, a Nonnucleoside Helicase-Primase Inhibitor targeting the Herpes Simplex Virus (HSV).
Multi-Country Herpes Immunotherapy Clinical Study Continues
Mar 5, 2024 · A leading global vaccine developer has announced that their investigational vaccine candidate for Herpes Simplex Virus (HSV) is undergoing a phase 1/2 clinical trial for the first time in Europe, England, and the United States. GlaxoSmithKline plc. (GSK), known for its extensive range of vaccines for various conditions, including RSV, meningitis, and shingles, is conducting an innovative study ...
Herpes Vaccine Candidate Advances in 2023 - Precision …
Jan 8, 2023 · When BioNTech SE announced that the first person was dosed in a first-in-human Phase 1 clinical trial with BNT163, a herpes simplex virus (HSV) vaccine candidate for the prevention of genital lesions caused by HSV-2 and potentially HSV-1, there was much enthusiasm generated by millions of people. BioNTech's placebo-controlled, observer-blinded, two-dose-escalation study was launched on ...
U.S. Government Takes Herpes Vaccine Development Lead
Apr 4, 2024 · Washington DC (Precision Vaccinations News). Herpes simplex viruses (HSV) are widely known to cause viral infections such as blisters around the face, and genital herpes usually affects the genital and buttocks area.
What’s the Difference Between Shingles and Chickenpox Vaccines?
Nov 2, 2017 · Shingrix shingles vaccine contains a lone protein isolated from the shell of the varicella zoster virus
34 Countries Identified in the Latest Polio Outbreak Alert
Jun 22, 2024 · The Global Polio Eradication Initiative (GPEI) released its weekly update, which indicated that three countries reported new polio cases as the poliovirus continues to spread in 2024. On June 19, 2024, the GPEI reported that Afghanistan confirmed one wild poliovirus type 1 (WPV1), bringing the total number of cases in 2024 to six. Nigeria reported three cases of circulating vaccine-derived ...
Three Novel Immune-based Therapies for HIV Cure Launch Clinical …
Apr 22, 2024 · Although antiretroviral treatment (ART) can help manage the impact of the Human Immunodeficiency Virus (HIV), it is not a cure. People living with HIV need to take the treatment for their entire lives to suppress viral replication and protect their immune systems.
Chronic Hepatitis B Treatment Receives U.S. FDA Fast Track …
Feb 13, 2024 · GSK plc announced today that the US Food and Drug Administration (FDA) has granted Fast Track designation for bepirovirsen, an investigational antisense oligonucleotide (ASO) for the treatment of chronic hepatitis B (CHB). GSK said on February 12, 2024, Bepirovirsen is the only single agent in phase III development that has shown the potential to achieve clinically meaningful functional cure ...
Ruvidar™ Found Effective in Destroying Herpes Simplex Virus
Sep 4, 2024 · Without a herpes preventive vaccine available in 2024, post-infection treatments offer patients their best option. Over the past few years, an antiviral drug named Acyclovir has been used to slow the spreading and lessen the symptoms of the Herpes Simplex Virus 1 (HSV-1) virus. However, Acyclovir will not cure herpes.
Mpox Travel Vaccine Recommendations Issued for Five African …
Aug 19, 2024 · (Precision Vaccinations News) The World Health Organization (WHO) today announced temporary (one-year) recommendations for States Parties experiencing the upsurge of monkeypox virus (MPXV) clade 1 detections, including, but not limited to, the Democratic Republic of the Congo (DRC), Burundi, Kenya, Rwanda, and Uganda.. The upsurge of mpox cases in the DRC in 2024 and its neighboring countries ...
- Some results have been removed